Xuchang Ketop Testing Research Ins Working Capital to Net Assets Ratio
Xuchang Ketop Testing Research Ins working capital to net assets ratio. Xuchang Ketop Testing Research Ins (003008) has a Working Capital to Net Assets ratio of 62.4% as of September 2025. Working capital of CN¥657.04 Million (current assets of CN¥701.43 Million minus current liabilities of CN¥44.39 Million) is measured against net assets of CN¥1.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Xuchang Ketop Testing Research Ins's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Xuchang Ketop Testing Research Ins (2016–2024)
Working capital to net assets ratio of Xuchang Ketop Testing Research Ins from 2016 to 2024. This chart shows how Xuchang Ketop Testing Research Ins's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 62.4%, reflecting working capital of CN¥657.04 Million against net assets of CN¥1.05 Billion CNY. See how many days can Xuchang Ketop Testing Research Ins fund operations to measure how many days the company can operate on defensive assets alone.
Xuchang Ketop Testing Research Ins Working Capital to Net Assets Ratio by Year (2016–2024)
Xuchang Ketop Testing Research Ins working capital to net assets ratio by year from 2016 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Xuchang Ketop Testing Research Ins from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Xuchang Ketop Testing Research Ins balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 61.1% | CN¥658.14 Million | CN¥1.08 Billion | CN¥735.39 Million | CN¥77.25 Million | ▲ +2.7 pp |
| 2023 | 58.3% | CN¥623.13 Million | CN¥1.07 Billion | CN¥708.13 Million | CN¥85.00 Million | ▲ +3.7 pp |
| 2022 | 54.7% | CN¥573.74 Million | CN¥1.05 Billion | CN¥661.39 Million | CN¥87.64 Million | ▼ -6.4 pp |
| 2021 | 61.1% | CN¥623.50 Million | CN¥1.02 Billion | CN¥679.05 Million | CN¥55.55 Million | ▼ -5.2 pp |
| 2020 | 66.3% | CN¥666.04 Million | CN¥1.00 Billion | CN¥716.75 Million | CN¥50.71 Million | ▲ +52.0 pp |
| 2019 | 14.3% | CN¥53.58 Million | CN¥374.07 Million | CN¥94.46 Million | CN¥40.89 Million | ▲ +10.0 pp |
| 2018 | 4.3% | CN¥12.68 Million | CN¥295.49 Million | CN¥109.56 Million | CN¥96.88 Million | ▼ -20.2 pp |
| 2017 | 24.5% | CN¥52.49 Million | CN¥214.64 Million | CN¥101.77 Million | CN¥49.28 Million | ▼ -15.4 pp |
| 2016 | 39.8% | CN¥56.68 Million | CN¥142.31 Million | CN¥97.46 Million | CN¥40.78 Million | — |